Open Accessibility Menu
Hide

Event Details

2021 END2Cancer: Emerging Nanotechnology and Drug Delivery Applications for Cancer Conference

  • Categories: Cancer

About This Event

  • Event Type:Educational Group
Details:

OU Health Stephenson Cancer Center is proud to host the 2021 END2CANCER: Emerging Nanotechnology and Drug Delivery Applications for Cancer conference from December 2-3, 2021 via Zoom. Registration is free!

The END2CANCER conference will start on the morning of December 2, 2021, and conclude in the afternoon of December 3, 2021. The conference will bridge laboratory research conducted in the areas of nanotechnology and drug delivery to clinical application for the detection, diagnosis, imaging and treatment of cancer. The conference will host keynote, plenary and invited lectures by eminent scientists who will discuss new and emerging concepts, technologies and challenges in translating nanomedicine from bench-to-bedside

Topics to be discussed include Gene and Drug Delivery, Combinatorial Targeted Approaches to Cancer Prevention and Treatment, Extracellular Vesicles, Theranostics, and Nano-ImmunoOncology.

We will have two new sessions this year! The “Women in Cancer Research” session will discuss challenges and ways to balance a successful career and personal lifestyle, and the “Pitch Your Research” session will be an opportunity for senior postdoctoral fellows and Assistant Professor researchers to present their work for job opportunities from potential employers.

The multi-disciplinary two-day conference will bring together physicians, basic scientists, engineers, physicists, chemists, post-doctoral fellows, high-school and college students, patient advocates, business professionals, educators and technology transfer specialists.

Students and fellows will have an opportunity to present and compete for awards in a poster session as well as in a special session titled “Art of Science in Light of Nanomedicine” allowing participants to display their best research as a photo with a caption.

For more information, visit End2Cancer.com

Registration